Anticoagulation management in haemodialysis patients with atrial fibrillation: evidence and opinion

AS De Vriese, G Heine - Nephrology Dialysis Transplantation, 2022 - academic.oup.com
In the absence of robust evidence to guide clinical decision-making, the optimal approach to
prevent stroke and systemic embolism in haemodialysis (HD) patients with atrial fibrillation …
被引用次数：47 相关文章

Anticoagulation management in haemodialysis patients with atrial fibrillation: evidence and opinion

AS De Vriese, G Heine - Nephrology Dialysis Transplantation, 2022 - academic.oup.com
In the absence of robust evidence to guide clinical decision-making, the optimal approach to
prevent stroke and systemic embolism in haemodialysis (HD) patients with atrial fibrillation …

Anticoagulation management in haemodialysis patients with atrial fibrillation: evidence and opinion.

AS De Vriese, G Heine - Nephrology Dialysis …, 2022 - search.ebscohost.com
In the absence of robust evidence to guide clinical decision-making, the optimal approach to
prevent stroke and systemic embolism in haemodialysis (HD) patients with atrial fibrillation …

Anticoagulation Management In Hemodialysis Patients With Atrial Fibrillation: Evidence And Opinion.

AS De Vriese, G Heine - … Publication of the European Dialysis and …, 2021 - europepmc.org
In the absence of robust evidence to guide clinical decision making, the optimal approach to
prevent stroke and systemic embolism in hemodialysis patients with atrial fibrillation (AF) …

Anticoagulation management in haemodialysis patients with atrial fibrillation: evidence and opinion

AS De Vriese, G Heine - … , dialysis, transplantation: official …, 2022 - pubmed.ncbi.nlm.nih.gov
In the absence of robust evidence to guide clinical decision-making, the optimal approach to
prevent stroke and systemic embolism in haemodialysis (HD) patients with atrial fibrillation …